PEG-Free Poly(2-oxazoline) Lipids Modulate mRNA-LNP Biodistribution and Expression

Commercial lipid nanoparticles often accumulate in the liver due to interactions with apolipoprotein E, raising concerns about hepatic toxicity during repeated dosing regimens.

To address this limitation, researchers tested PEG-free tunable poly(2-oxazoline) lipids to modulate messenger RNA delivery and expression in vivo.

Traditional formulations rely on polyethylene glycol to stabilize the particle structure. However, investigators synthesized alternative polymers via living cationic ring-opening polymerization to achieve precise chain length control.

The resulting conjugates were evaluated across intramuscular, intravenous, and intratumoral injections. Short hydrophilic chains enhanced transfection efficiency while reducing off-target organ accumulation.

Investigators produced eight distinct polymer batches using substituted 2-oxazolines. The synthesis yielded materials with low dispersity values ranging from 1.007 to 1.275, according to the published data.

Polymer Characterization Metrics
Polymer Batch Code Nominal DP GPC $M_n$ Dispersity ($\text{\O}$)
PMeOx V6 10 673 1.007
PMeOx V4 20 1,004 1.039
PEtOx V3 10 972 1.024
PEtOx V1 20 1,887 1.061

Fourier transform infrared spectroscopy confirmed successful azide termination across all batches near the 2100 cm−1 wavenumber. Gel permeation chromatography showed lower absolute molecular weights compared to nuclear magnetic resonance assessments due to calibration differences with poly(methyl methacrylate) standards.

Partial specific volume measurements indicated that poly(2-ethyl-2-oxazoline) exhibits higher values than poly(2-methyl-2-oxazoline) at equivalent degrees of polymerization. This difference reflects the bulkier ethyl side chains present on the polymer architecture.

Transfection screening across HEK293, DC2.4, IC21, and 4T1 cell lines identified degree-of-polymerization 10 and 20 candidates as top performers. Short-chain formulations consistently matched or exceeded the expression efficiency of standard PEG-2000 particles.

In vivo evaluations demonstrated that poly(2-oxazoline) lipids increased muscle and brain tumor expression up to threefold. The formulations also significantly boosted accumulation in extrahepatic tissues such as lymph nodes and the spleen.

Commercial lipid nanoparticles typically show rising liver luminescence between 4 and 24 hours postinjection. Conversely, the tested polymer conjugates exhibited decreasing hepatic signals over the same monitoring window.

Gel permeation chromatography uses poly(methyl methacrylate) standards that differ in hydrodynamic volume and solvation behavior from poly(2-oxazolines), leading to systematic estimation variances.

Formulations containing 10% sucrose as a cryoprotectant were frozen at −80°C for one week before investigators compared HEK293 transfection capabilities.